晚期肝细胞癌管理中的多学科方法：探索未来方向。
Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions.
作者信息
Liu Xin-Jin, Lin Yi-Xiu, Chen Liu-Xiang, Yang Wen-Juan, Hu Bing
机构信息
Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
出版信息
World J Gastrointest Oncol. 2024 Oct 15;16(10):4052-4054. doi: 10.4251/wjgo.v16.i10.4052.
Recently, we read the article "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature" published in the . The prognosis of advanced hepatocellular carcinoma (HCC) is poor, and multidisciplinary comprehensive treatment is currently the main research direction. This case report demonstrated the efficacy of the combination therapy of transcatheter arterial chemoembolization, hepatic arterial infusion chemotherapy, epclusa, lenvatinib and sintilimab for a patient with advanced HCC, and the report can serve as a reference for clinical practice. We would also like to share some of our views.
最近，我们阅读了发表在《 》上的文章《多学科治疗后晚期巨大肝细胞癌病理成功转化肝切除术：一例报告及文献复习》。晚期肝细胞癌（HCC）预后较差，多学科综合治疗是目前主要的研究方向。本病例报告展示了经动脉化疗栓塞、肝动脉灌注化疗、丙通沙、仑伐替尼和信迪利单抗联合治疗晚期HCC患者的疗效，该报告可为临床实践提供参考。我们也想分享一些我们的观点。
Zotero 插件